RANDOMIZED, DOUBLE-BLIND CROSSOVER COMPARISON OF ONCE-DAILY CAPTOPRIL AND LISINOPRIL IN PATIENTS WITH MILD TO MODERATE HYPERTENSION - A COMMUNITY-BASED STUDY

被引:1
作者
SMITH, AJ [1 ]
GILLIES, A [1 ]
CARNEY, S [1 ]
TAYLOR, M [1 ]
HARVEY, D [1 ]
RATCLIFFE, I [1 ]
GANDY, M [1 ]
机构
[1] ICI AUSTRALIA OPERAT PTY LTD, MELBOURNE, AUSTRALIA
关键词
HYPERTENSION; CAPTOPRIL; LISINOPRIL; TOLERANCE; ANGIOTENSIN CONVERTING ENZYME INHIBITION;
D O I
10.3109/10641969309032944
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Of twenty-five patients with mild to moderate hypertension, recruited and managed in the community, seventeen responded fully to, and completed a randomised cross-over study of, captopril (ceiling dose 100 mg) compared with lisinopril (ceiling dose 40 mg) both given as a single daily dose. Mean supine and standing blood pressures measured at the end of the dose interval were significantly reduced compared to placebo by both compounds at three and six weeks. However, a consistent, significant increase in blood pressure occurred between three and six weeks in both arms of the study despite good and unchanged compliance with a fixed dose of each medication. Both captopril and lisinopril were well tolerated. Drug-related cough was the principal adverse effect.
引用
收藏
页码:423 / 434
页数:12
相关论文
共 9 条
[1]   IS CAPTOPRIL EFFECTIVE IN CONTROLLING BLOOD-PRESSURE WHEN ADMINISTERED ONCE DAILY - AN ASSESSMENT USING 24-H AMBULATORY BLOOD-PRESSURE MONITORING [J].
FREWIN, DB ;
BUIK, C ;
RENNIE, G .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (01) :11-15
[2]  
GROEL JT, 1983, HYPERTENSION, V5, P145
[3]   EFFECT OF LONG-TERM TREATMENT WITH AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ON THE RENIN-ANGIOTENSIN SYSTEM IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
MORISHITA, R ;
HIGAKI, J ;
OKUNISHI, H ;
KAWAMOTO, T ;
ISHII, K ;
NAKAMURA, F ;
KATAHIRA, K ;
NAGANO, M ;
MIKAMI, H ;
MIYAZAKI, M ;
OGIHARA, T .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1991, 18 (10) :685-690
[4]   PLASMA ANGIOTENSIN-II AND THE ANTIHYPERTENSIVE ACTION OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION [J].
NUSSBERGER, J ;
WAEBER, B ;
BRUNNER, HR .
AMERICAN JOURNAL OF HYPERTENSION, 1989, 2 (04) :286-293
[5]  
SCHOENBERGER AJ, 1986, J CLIN HYPERTENS, V4, P379
[6]   LONG-TERM CAPTOPRIL THERAPY - EVOLVING HEMODYNAMIC-EFFECTS [J].
SULLIVAN, JM ;
TAYLOR, JC ;
PATRICK, DR ;
JOHNSON, JG ;
RATTS, TE ;
MUIRHEAD, EE .
JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (10) :450-458
[7]   ENALAPRIL MALEATE AND A LYSINE ANALOG (MK-521) - DISPOSITION IN MAN [J].
ULM, EH ;
HICHENS, M ;
GOMEZ, HJ ;
TILL, AE ;
HAND, E ;
VASSIL, TC ;
BIOLLAZ, J ;
BRUNNER, HR ;
SCHELLING, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :357-362
[8]  
VANDENMEIRACKER AH, 1992, J HYPERTENS, V10, P803
[9]   CAPTOPRIL WITHDRAWAL AFTER CHRONIC THERAPY [J].
VLASSES, PH ;
KOFFER, H ;
FERGUSON, RK ;
GREEN, PJ ;
MCELWAIN, GE .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1981, 3 (05) :929-937